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Abstract
Background: Non-Hodgkin lymphoma (NHL) is a malignancy etiologically linked to immunomodulatory exposures and
disorders. Endogenous female sex hormones may modify immune function and influence NHL risk. Few studies have
examined associations between reproductive factors, which can serve as surrogates for such hormonal exposures, and NHL
risk by subtype.
Methodology/Principal Findings: Women in the California Teachers Study cohort provided detailed data in 1995–1996 on
reproductive history. Follow-up through 2007 identified 574 women with incident B-cell NHL. Hazard rate ratios (RR) and
95% confidence intervals (CI) were estimated using Cox proportional hazards models to assess associations between
reproductive factors and all B-cell NHL combined, diffuse large B-cell lymphomas, follicular lymphomas, and B-cell chronic
lymphocytic leukemias/small lymphocytic lymphomas. Pregnancy was marginally associated with lower risk of B-cell NHL
(RR=0.84, 95% CI=0.68–1.04). Much of the reduction in risk was observed after one full-term pregnancy relative to
nulligravid women (RR=0.75, 95% CI=0.54–1.06; P for trend ,0.01), particularly for diffuse large B-cell lymphomas (P for
trend=0.13), but not among women who had only incomplete pregnancies. Age at first full-term pregnancy was marginally
inversely associated with B-cell NHL risk overall (P for trend=0.08) and for diffuse large B-cell lymphomas (P for
trend=0.056). Breast feeding was not associated with B-cell NHL risk overall or by subtype.
Conclusions: Full-term pregnancy and early age at first full-term pregnancy account for most of the observed reduction in
B-cell NHL risk associated with gravidity. Pregnancy-related hormonal exposures, including prolonged and high-level
exposure to progesterone during a full-term pregnancy may inhibit development of B-cell NHL.
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Introduction
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of
lymphoid malignancies. In the US, NHL incidence rates have
risen steadily since the early 1940s [1], such that NHL is now the
fifth most common cancer among US men and women [2].
Although immunodeficiency, autoimmunity, and certain viral
infections have been associated with increased risk of some NHLs,
the risk factors responsible for the development of most NHLs
remain elusive [3,4]. The observation that men have consistently
higher incidence rates of NHL than women [5], coupled with
biological evidence that sex steroid hormones modulate the
immune system [6], suggests a potential influence of endogenously
produced female hormones on lymphomagenesis. Case-control
[7–12] and cohort studies [13–16] that have used various
menstrual and reproductive characteristics to assess the relation-
ship between endogenous estrogen exposure and NHL risk in
women have produced inconsistent results.
Different NHL histologic subtypes are thought to arise from the
clonal expansion of malignant cells during progressive stages of
lymphocyte differentiation [17]. The diverse incidence patterns
observed for distinct histologic subtypes of NHL suggest that
subtypes differ etiologically [5], but few studies [11,12,16] have
examined menstrual and reproductive risk factors for NHL
subtypes. Zhang et al [11] showed an inverse association with
number of pregnancies, which was particularly pronounced for
diffuse NHL, as defined by the Working Formulation [18].
Similarly, Lee et al [12] found that women with four or more
pregnancies had decreased risk of diffuse large-cell lymphoma
(defined by the REAL classification [19], and not limited to B-cell
NHL) compared to women who had never been pregnant. In
contrast to these case-control studies, a recent cohort study [16]
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large B-cell lymphoma, classified according to the World Health
Organization [20] and the International Lymphoma Epidemiol-
ogy Consortium (InterLymph) guidelines [21]. Morton et al. [16]
observed a non-significant reduction in NHL risk associated with
older age at menarche that appeared restricted to follicular
lymphoma risk. We used comparatively large sample sizes of the
common NHL histologic subtypes from the prospective California
Teachers Study to address whether menstrual and reproductive
factors influence risk of common B-cell NHL subtypes.
Materials and Methods
Study Population
The California Teachers Study is a prospective cohort
comprising 133,479 female public school professionals recruited
through the California State Teachers Retirement System. In
1995-1996, participants completed a detailed self-administered
questionnaire, which gathered information on menstrual and
reproductive factors, hormone use, medical history, and lifestyle
factors. A detailed description of this cohort has been published
elsewhere [22].
For this analysis, we excluded sequentially women who were not
California residents at the time the baseline questionnaire was
completed (n=8,867), had limited their participation to breast
cancer research (n=18), had a prior history of a hematologic
malignancy (n=536) or whose history of cancer was unknown
(n=663), were 85 years of age or older at baseline (n=2179), were
pregnant at the time they completed the questionnaire (n=157),
or had never had a first menstrual period (n=55). Our final
analytic cohort consisted of 121,004 women.
Ethics Statement
Completion of the self-administered written questionnaire was
considered to imply informed consent. A small subset of women
restricted use of their information to breast cancer research and
have been excluded from this analysis. Use of human subjects in
this study was approved by the Institutional Review Boards at the
City of Hope, University of Southern California, Northern
California Cancer Center and University of California Irvine,
and by the Committee for the Protection of Human Subjects,
California Health and Human Services Agency.
Case Ascertainment and Follow-Up
California law requires the reporting of all new cancer diagnoses
to the statewide, population-based California Cancer Registry
[23]. As a result, the registry receives information on over 99% of
all cancers diagnosed in California (www.ccrcal.org). Annual
linkages to the California Cancer Registry identified 574 incident
cases of B-cell NHL (International Classification of Diseases for
Oncology, third edition [ICD-O-3] morphology codes: 9590,
9591, 9670–9675, 9678–9699, 9727, 9823, 9832, 9835, 9836) in
the analytic cohort through December 31, 2007. Among the cases
identified were 155 diffuse large B-cell lymphomas (9678–9680,
9684), 121 follicular lymphomas (9690–9698), and 124 B-cell
chronic lymphocytic leukemias/small lymphocytic lymphomas
(CLL/SLL; 9670, 9823).
Follow-up for each participant began on the date the baseline
questionnaire was completed and continued until the first of the
following outcomes: a first diagnosis of a hematologic malignancy,
a permanent move outside of California, death, or the end of the
follow-up period (December 31, 2007). Women who were
diagnosed during follow up with T-cell NHL, multiple myeloma,
Hodgkin lymphoma or leukemia other than chronic lymphocytic
and prolymphocytic leukemias were censored on their dates of
diagnosis. The status of California residence was monitored
through linkages with the California Department of Motor
Vehicles and the U.S. Postal Service national change of address
database, as well as through address corrections received from the
post office and change-of-address postcards submitted by partic-
ipants. Information on the date and cause of death were obtained
from linkages to state and national mortality files [22].
Exposure Assessment
At baseline, participants provided detailed information on age
at menarche; whether they had ever been pregnant (yes or no); age
at and outcome of each pregnancy (induced abortion, miscarriage,
tubal pregnancy, stillbirth or live birth); if they had breastfed, total
duration of breast feeding; and menopausal status. In this analysis,
full-term pregnancy combined live births and stillbirths. When
assessing associations with number of full-term pregnancies, we
used women who had never been pregnant (nulligravid women) as
our reference group, and grouped together women who had had
an induced abortion, miscarriage, or tubal pregnancy, but no live
birth or stillbirth. We also examined the effects of age at first full-
term pregnancy and duration of breast feeding among parous
women.
Perimenopausal women were defined as women whose
menstrual periods had stopped within 6 months of baseline.
Women were considered postmenopausal if their menstrual
periods had stopped (due to natural menopause or bilateral
oophorectomy) more than 6 months before completing the
baseline questionnaire or they were 56 years of age or older and
not considered premenopausal or perimenopausal. Postmeno-
pausal women were subdivided according to their use of hormone
therapy (HT) into women who had never used HT for menopausal
symptoms and those who had used HT (estrogen alone or
combined estrogen and progestin therapy) for menopausal
symptoms.
Statistical Analyses
We used multivariable Cox proportional hazards regression
models to investigate associations between reproductive factors
and all B-cell NHL combined as well as for the 3 most common
NHL subtypes. Hazard rate ratios (RR) and 95% confidence
intervals (CI) were estimated using age in days from baseline until
the end of follow-up as the time scale in the Cox regression
models. All models were stratified by age in years at baseline.
We assessed race (white, non-white, or unknown), residential
area-level socioeconomic status (quartiles of California statewide
distribution [24] or unknown), first-degree family history of
lymphoma (no, yes, or unknown), body mass index (BMI) at
baseline (,20 kg/m
2, 20–24.9 kg/m
2, 25–29.9 kg/m
2, $30 kg/
m
2, or unknown), alcohol consumption in the year before joining
the cohort (none, ,15 g/day, $15 g/day, or unknown), smoking
status at baseline (never, former, current, or unknown), oral
contraceptive use (no, yes, or unknown), menopausal and HT use
status (premenopausal, peri-menopausal, postmenopausal with no
HT use, postmenopausal with any HT use, postmenopausal with
unknown HT use, or unknown menopausal/HT use status), and
any prior diagnosis of diabetes (no or yes) as potential confounders
of the relationship between reproductive variables and risk of B-
cell NHL. None of these factors altered risk estimates by as much
as 5% for overall B-cell NHL, and therefore none were included in
the final models. We included age at menarche in years (,12, 12,
13+, or unknown) as a covariate in all regression models. Age at
and number of pregnancies overall, or full-term pregnancies, were
mutually adjusted for one another.
Reproductive Factors and NHL
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within each category were included in the regression models for
number of full-term pregnancies, months of breast feeding, and
age at first full-term pregnancy. Two-sided P values are reported
for tests for trend. We did not adjust P values for multiple
comparisons. All statistical analyses were performed using SAS
version 9.1 (SAS Institute Inc, Cary, NC).
Results
The average length of follow-up for women in the analytic
cohort was 11 years. The mean ages (6SD) at diagnosis were
69.5611.6 years (range, 33–93) for all B-cell NHL combined,
69.3611.7 years (range, 33–92) for diffuse large B-cell lymphoma,
66.3612.4 years (range, 35–90) for follicular lymphoma, and
72.169.7 (range, 48–92) for CLL/SLL.
Table 1 provides the age-adjusted distribution of several
participant characteristics according to number of full-term
pregnancies. At baseline, 56.6% of participants reported at least
2 full-term pregnancies. Women who had at least 2 full-term
pregnancies were more likely to be white and older, but less likely
to be current smokers at baseline or to have consumed at least
15 grams/day of alcohol in the year prior to joining the cohort.
Women who had at least 3 full-term pregnancies were more likely
to be postmenopausal.
Gravid women (women who had been pregnant) had lower risk
of overall B-cell NHL than nulligravid women (women who had
never been pregnant) (RR=0.84, 95% CI=0.68–1.04; Table 2).
Full-term pregnancy appeared to account for most of the
reduction in risk, since we saw no association with NHL risk
among women who had been pregnant but never carried to full-
term, compared with nulligravid women (RR=1.12, 95%
CI=0.74–1.70). Among parous women (women who gave birth),
the reduced risk was relatively constant with increasing number of
full-term pregnancies compared to nulligravid women (P for trend
,0.01). The inverse association with number of full-term
pregnancies was strongest for diffuse large B-cell lymphoma,
although some indication of reduced risk was also observed among
the other histologic subtypes examined.
Among parous women, those who had a first full-term
pregnancy at age 25 years or older were at higher risk of overall
B-cell NHL than those who had a first full-term pregnancy before
age 25 (P for trend with increasing age at first full-term
pregnancy=0.08). This association was most apparent for diffuse
large B-cell lymphoma (P for trend=0.056), but also for follicular
lymphomas (P for trend=0.11). Among parous women, breast-
feeding was not associated with risk of overall B-cell NHL or any
of the histologic subtypes. Although not statistically significant,
some suggestion of reduced risk was observed between later age at
menarche and overall B-cell NHL; the RR estimate was lowest for
diffuse large B-cell lymphoma.
Secondary analyses restricted to women whose reproductive
history at baseline was likely to remain unchanged throughout the
cohort follow-up period (i.e., $45 years of age at baseline) yielded
similar results (data not shown).
Discussion
Because women generally have lower incidence rates of most
NHL subtypes than men [5] and sex hormones have profound
effects on the immune system [6], we hypothesized that
endogenous estrogen exposure would confer a reduced risk of B-
cell NHL. Inconsistencies reported in the literature may be the
result of combining histologic subtypes which have heterogeneous
clinical features and incidence patterns and thus are likely to
possess distinct sets of risk factors [5]. Although we observed about
a 30% decreased risk of B-cell NHL overall associated with full-
term pregnancies, which induces prolonged exposure to increased
circulating estrogen levels [25,26], our study results are not
consistent with a major role for endogenous estrogens in the
etiology of B-cell NHL. If our hypothesis was correct, we would
expect that late age at menarche would increase the risk of B-cell
NHL, as a late age at menarche is associated with lower estrogen
levels [27,28]. Instead, later age at menarche was non-significantly
associated with reduced risk of B-cell NHL.
Two previous studies have looked at the association between
age at menarche and risk of NHL as a single entity [11,14],
whereas two other studies examined the association with risk by
NHL subtypes [12,16]. No association was observed in the
prospective Iowa Women’s Health Study [14] or in a population-
based case-control study in the San Francisco Bay Area of
California [12]. The NIH-AARP Diet and Health Study Cohort
observed a non-significant reduction in follicular lymphoma risk
among women who had their first menstrual period at age 15 or
older compared to women who began menarche at age 12 or
younger (RR=0.58, 95% CI=0.25–1.35) [12,16]. On the other
hand, a population-based case-control study in Connecticut [11]
found an increased risk among women with age at menarche at 15
years or older, compared with those with age at menarche younger
than 12 years (OR=1.5, 95% CI=1.0–2.2), with no apparent
dose-response trend. We observed a non-significant reduced risk of
overall B-cell NHL associated with later age at menarche (.12
years vs ,12 years RR=0.86, 95% CI=0.69–1.05), which was
most pronounced for diffuse large B-cell lymphoma. Given the
inconsistency in the literature and lack of statistically significant
results, the evidence suggests age at menarche does not serve as a
surrogate for risk of B-cell NHL or any of the common NHL
histologic subtypes.
The association between pregnancy and overall NHL risk has
also been inconsistent in previous studies. A population-based
case-control study in Los Angeles County, California [10], and the
Iowa Women’s Health Study [14] found some indication of an
increased risk of NHL among parous women, although the relative
risk estimates and trends were not statistically significant. Three
studies found no association between pregnancy and overall NHL
risk [8,9,16], whereas the Connecticut case-control study found a
statistically significant inverse association between number of full-
term births and overall NHL risk [11]. NHL risk was reduced
among women with at least 4 full-term pregnancies compared to
women who had never been pregnant (OR=0.6, 95% CI=0.4–
0.9).
Inconsistencies persist when parity is examined by NHL
histologic subtypes. A prospective, registry-based study [8]
observed a non-significant inverse trend between parity and
CLL risk, but did not examine other NHL subtypes separately.
Lee et al. [12] reported a statistically significant reduced risk for
diffuse large-cell lymphoma, but not for follicular lymphoma.
Whereas Zhang et al. [11] observed a non-significant reduced risk
of follicular lymphoma and a marginally significant reduced risk of
diffuse large B-cell lymphoma with number of full-term pregnan-
cies. Morton et al. [8,9,16] did not observe an association of parity
with any NHL subtype. In our cohort study, the inverse
association with number of full-term pregnancies was most
pronounced for diffuse large B-cell lymphoma risk. While the
lack of a trend among parous women in our data could result from
a threshold effect, the overall inconsistency in the literature also
suggests our observations may be a chance finding.
Most studies did not find a statistically significant association
between age at first full-term pregnancy and NHL risk overall,
Reproductive Factors and NHL
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who had a first full-term pregnancy between ages 25 to 30 [8,10–
12,14]. Late age at first full-term pregnancy was a risk factor for
overall NHL in a hospital-based case-control study in Sweden [7].
By contrast, in a registry-based cohort study in Denmark, age at
first birth was inversely associated with NHL risk, as women whose
first birth occurred between ages 15 and 19 years had the highest
risk [15]. We found a marginally statistically significant positive
association between age at first full-term pregnancy and risk of
overall B-cell NHL and diffuse large B-cell lymphoma, with some
suggestion for increased follicular lymphoma risk, but not CLL/
SLL. Although Lee et al. [12] also investigated different NHL
subtypes, they used nulliparous women as reference group instead
of restricting the analysis to parous women, making our results
Table 1. Selected baseline characteristics of 121,004 eligible women in the California Teachers Study by number of full-term
pregnancies at baseline.
Characteristic Subcategory N (total) Number of full-term pregnancies (%)
0123 + Unknown
Total 121004 26.1 15.4 32.2 24.4 1.9
Age categories (years) ,35 12596 56.0 21.6 16.4 4.3 1.8
35–44 21417 28.8 16.9 36.9 16.2 1.2
45–54 36455 23.9 17.0 39.6 18.2 1.3
55–64 23464 19.5 11.8 31.6 35.4 1.8
65–74 17790 17.5 10.5 26.2 43.1 2.8
75–84 9282 20.5 16.3 27.4 31.2 4.6
Race Non-Hispanic white 104636 24.1 15.2 35.5 23.7 1.5
Other races/ethnicities 15373 27.1 17.9 30.4 22.3 2.3
Unknown race/ethnicity 995 22.0 15.4 29.0 27.0 6.7
First-degree family history of lymphoma No 114072 24.5 15.5 34.9 23.5 1.6
Yes 3177 21.8 15.2 35.7 25.9 1.5
Unknown/Adopted 3755 26.5 17.6 31.4 21.9 2.7
Socioeconomic status Below statewide median 26037 25.3 15.7 31.3 26.0 1.7
Above statewide median 93422 24.2 15.5 35.8 22.9 1.6
Unknown 1545 25.5 15.6 32.3 24.7 1.9
Diagnosed with diabetes No 117557 24.5 15.5 35.0 23.4 1.6
Yes 3447 23.7 16.1 29.4 29.1 1.9
Alcohol consumption (grams/day) None 38533 23.1 15.5 33.9 25.8 1.7
,15 56877 24.1 15.7 36.3 22.5 1.5
$15 19285 28.0 15.2 33.0 22.1 1.6
Unknown 6309 25.2 16.5 32.6 23.1 2.6
Smoking status Never 79453 24.2 15.2 35.5 23.6 1.6
Former 34652 24.3 16.2 34.3 23.7 1.6
Current 6176 29.0 16.9 30.5 21.8 1.8
Unknown 723 25.1 17.1 31.8 22.5 3.5
Body mass index (kg/m
2) 16–19.9 12614 29.3 17.1 33.6 18.5 1.5
20–24.9 58086 24.2 15.9 36.1 22.3 1.5
25–29.9 29061 22.1 14.4 35.0 26.9 1.6
30–54.9 16399 26.4 15.1 32.0 25.0 1.5
Unknown 4844 22.3 15.6 31.5 26.7 3.9
Oral contraceptive use No 38485 31.0 11.8 25.5 30.2 1.3
Yes 79023 22.3 17.0 38.7 21.6 0.4
Unknown 3496 21.1 11.3 17.8 12.1 37.7
Menopausal status/hormone therapy (HT) use Premenopausal 47781 28.2 17.9 36.9 16.2 0.8
Perimenopausal 2514 25.7 16.8 38.6 18.4 0.5
Postmenopausal, no HT use 14056 24.1 13.6 28.2 32.0 2.1
Postmenopausal, HT use 46588 21.3 13.8 33.7 29.5 1.8
Postmenopausal, unknown HT use 4646 21.1 13.8 31.0 30.8 3.3
Unknown menopuasal/HT use status 5419 21.4 14.8 39.5 19.8 4.5
doi:10.1371/journal.pone.0008135.t001
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had no association with overall NHL risk or follicular lymphoma,
but women who had their first child after age 28 had a statistically
significant decreased risk of diffuse large-cell lymphoma.
Consistent with findings from a previous case-control study
[10], breast feeding did not influence NHL risk among parous
women in our study. The Iowa Women’s Health Study [14], the
only other cohort study to assess the effect of breast feeding, found
that parous women who had breast fed at least 3 children had a
reduced risk of NHL when considered as a single entity.
If our observed inverse association between pregnancy and B-
cell NHL risk in our study is true, it prompts the question of how
pregnancy might influence NHL development. To promote
proper implantation and protect the fetal allograft from rejection
during pregnancy, the maternal immunologic state shifts from a
predominantly cell-mediated response to a humoral response
(reviewed in [29]). One potential mechanism for this shift may
involve the steady increase in circulating progesterone levels that
occurs throughout pregnancy [30]. Current evidence suggests that
once a sufficient level is reached, progesterone stimulates the
Table 2. Relative risk estimates and 95% confidence intervals for the association between menstrual and reproductive factors and
B-cell NHL risk overall and by histologic subtype in the California Teachers Study.
All cases Diffuse large B-cell Follicular CLL/SLL
Baseline variable Subcategory
Person-
years
Cases
(574)
Multivariate RR
(95% CI)
Cases
(155)
RR
(95% CI)
Cases
(121) RR (95% CI)
Cases
(124) RR (95% CI)
Age at menarche
1 ,12 years 297699 134 1.00 40 1.00 28 1.00 27 1.00
12 years 359691 160 0.98 (0.78–1.23) 39 0.80 (0.51–1.24) 34 1.02 (0.62–1.68) 34 1.02 (0.62–1.69)
.12 years 653476 270 0.86 (0.69–1.05) 74 0.78 (0.53–1.15) 56 0.88 (0.56–1.39) 60 0.93 (0.59–1.46)
Unknown 17763 10 2 3 3
P trend 0.10 0.25 0.51 0.70
Ever pregnant
{ No 266779 109 1.00 29 1.00 24 1.00 21 1.00
Yes 1046397 455 0.84 (0.68–1.04) 124 0.86 (0.57–1.29) 94 0.82 (0.52–1.29) 100 0.94 (0.58–1.50)
Unknown 15453 10 2 3 3
Number of FTP
{{ Never pregnant 266779 109 1.00 29 1.00 24 1.00 21 1.00
No FTP 77654 28 1.12 (0.74–1.70) 6 0.90 (0.37–2.18) 8 1.34 (0.60–2.99) 1 0.24 (0.03–1.75)
1 204480 78 0.75 (0.54–1.06) 25 0.76 (0.40–1.45) 18 0.69 (0.33–1.45) 15 0.77 (0.36–1.64)
2 433421 170 0.72 (0.54–0.95) 44 0.64 (0.37–1.12) 31 0.56 (0.30–1.06) 46 0.98 (0.54–1.78)
3+ 322158 176 0.71 (0.55–0.93) 47 0.68 (0.41–1.14) 37 0.73 (0.41–1.30) 38 0.71 (0.39–1.27)
Unknown 24136 13 4 3 3
P trend ,0.01 0.13 0.21 0.41
Number of
pregnancies
{{
Never pregnant 266779 109 1.00 29 1.00 24 1.00 21 1.00
1 182735 79 0.94 (0.68–1.31) 24 0.97 (0.521.83) 17 0.82 (0.40–1.68) 14 0.89 (0.42–1.89)
2 351934 141 0.79 (0.60–1.05) 37 0.74 (0.43–1.29) 26 0.67 (0.36–1.25) 35 0.97 (0.53–1.79)
3 260357 109 0.73 (0.55–0.98) 29 0.70 (0.40–1.23) 24 0.79 (0.43–1.46) 24 0.77 (0.41–1.46)
4+ 242121 123 0.78 (0.59–1.02) 32 0.74 (0.43–1.26) 27 0.87 (0.49–1.56) 27 0.80 (0.44–1.46)
Unknown 24704 13 4 3 3
P trend 0.01 0.10 0.54 0.23
Age at first full-term
pregnancy
{{||
,25 years 344503 151 1.00 38 1.00 30 1.00 34 1.00
25–29 years 391649 185 1.27 (1.02–1.58) 46 1.26 (0.81–1.96) 34 1.51 (0.87–2.61) 49 1.47 (0.94–2.30)
$30 years 223888 88 1.21 (0.91–1.61) 32 1.73 (1.04–2.90) 22 1.58 (0.80–3.10) 16 0.99 (0.53–1.86)
P trend 0.08 0.056 0.11 0.69
Duration of breast
feeding
{||
None 212897 125 1.00 34 1.00 28 1.00 31 1.00
,6 months 231266 108 0.94 (0.73–1.22) 32 1.01 (0.62–1.64) 17 0.65 (0.35–1.18) 24 0.87 (0.51–1.48)
6–11 months 180927 69 0.93 (0.69–1.25) 23 1.13 (0.66–1.92) 15 0.84 (0.45–1.58) 12 0.70 (0.36–1.37)
12+ months 330667 118 1.02 (0.79–1.32) 26 0.81 (0.48–1.36) 24 0.82 (0.47–1.44) 31 1.23 (0.74–2.03)
P trend 0.68 0.56 0.79 0.50
FTP: Full-term pregnancy RR=relative risk; CI=confidence interval; CLL=chronic lymphocytic leukemia; SLL=small lymphocytic lymphoma.
{Adjusted for age at menarche.
{Number of pregnancies/full-term pregnancies and age at first pregnancy/first full-term pregnancy were mutually adjusted for each other.
1Adjusted for ever been pregnant.
||Limited to women with at least one full-term pregnancy.
doi:10.1371/journal.pone.0008135.t002
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one and PIBF inhibit T-helper 1 (Th1) cells from producing pro-
inflammatory cytokines that activate cell-mediated responses (e.g.,
interferon-gamma, tumor necrosis factor-alpha, and interleukin 2
(IL-2) and stimulate Th2 cell secretion of cytokines that promote
B-cell antibody production (e.g., IL-4, IL-5, IL-6, and IL-10), some
of which may be anti-inflammatory. IL-4 further induces Th2
ctyokine synthesis and inhibits Th1 cytokine secretion, reinforcing
this shift toward humoral immunity [29,31].
High progesterone levels, alone or in conjunction with high
estrogen exposure, may provide an alternative explanation for the
putative protective effect of pregnancy on B-cell NHL risk. The
effect may be mediated directly by inducing the differentiation of
B-lymphocytes to produce antibodies, or indirectly by promoting a
systemic anti-inflammatory environment. Future studies examin-
ing cytokine profiles and subsequent B-cell NHL risk among
women according to type and dose of exogenous hormone use (i.e.,
oral contraceptives and postmenopausal hormones) may help tease
out the potential effects of estrogen and progesterone.
Our study benefits from its large size, prospective design, and
virtually complete case ascertainment through the statewide,
population-based California Cancer Registry. Previous popula-
tion-based case-control studies were unable to interview a large
proportion of eligible cases because of severe illness or death
[10,32,33]. The prospective nature of our study eliminates the
potential for survival bias, particularly among patients diagnosed
with more aggressive histologic subtypes, such as diffuse large B-
cell lymphoma [17]. Over an average 11 years of follow-up, a
modest number of cases were available (N=574) for analyses of
overall B-cell NHL risk. Although we examined the largest
number of common histologic subtypes for a prospective study
compared to prior literature, our samples sizes were still limited for
NHL histologic subtype analyses, and we lacked sufficient power
to examine associations with less common subtypes. We observed
some heterogeneity among the histologic subtypes, highlighting
the need to analyze the NHL subtypes as distinct diseases.
However, some of the apparent heterogeneity may have been due
to the lack of power to detect associations with certain subtypes.
Like other cohort studies, ours may have been subject to some
exposure misclassification among women whose reproductive
history changed after the baseline questionnaire. However, our
results did not differ when we repeated analyses including only
participants $45 years of age at baseline whose reproductive
history was unlikely to change. A final consideration regards the
limited generalizability of our results, as the CTS does not include
women in the lowest socioeconomic status category and is
composed primarily of white, non-Hispanic participants (86% of
the cohort). Although adjusting for race did not alter our risk
estimates by as much as 5%, incidence rates for histologic subtypes
differ substantially by race [5], and thus necessitate further study of
reproductive factors in B-cell NHL risk among minority
populations.
In summary, our results do not support a simple protective role
for endogenous estrogen in B-cell NHL development, but if true,
may instead suggest a relevant immunomodulatory effect of high
progesterone concentrations that are encountered during late
pregnancy. Histologic subtype-specific associations differ, support-
ing the notion that B-cell NHL histologic subtypes are indeed
etiologically and clinically distinct diseases. Future prospective
studies with long follow-up periods are needed to accrue sufficient
sample sizes to examine risk factor associations with risk of
individual B-cell NHL histologic subtypes, and perhaps with T-cell
NHL. Studies assessing detailed exogenous hormone use could
also help tease out whether estrogen and progesterone contribute
to B-cell NHL risk, and perhaps help explain the gender disparity
in NHL incidence.
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